ADRB1 and Ventricular arrhythmia: Therefore, the appearance of β1-AR autoantibodies in the peripheral circulation is closely related to the increase in fatal ventricular arrhythmias, sudden death, and all-cause and cardiac mortality in patients with DCM [36–39].